Home > Insider Trading > Filing (0001127602-21-019437)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
64803	Cvs Health Corp	CVS	Retail-Drug Stores And Proprietary Stores (5912)	050494040

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1844305	P Daniel Finke	One Cvs Drive Woonsocket RI 02895	Evp/Pres, Health Care Benefits	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-06-07	32,320	$54.19	60,904	No	4	M	Direct
Common Stock	Disposition	2021-06-07	37,594	$86.60	23,310	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option	Disposition	2021-06-07	32,320	$0.00	32,320	$54.19

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
32,322	2020-04-01	2029-04-01	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock (Pep)	3,042	Direct
Common Stock (Restricted)	25,701	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Option	$58.34	2021-04-01	2030-04-01	54,332	54,332	Direct
Common Stock	Stock Option	$74.30	2022-04-01	2031-04-01	82,066	82,066	Direct
Common Stock	Stock Option	$52.37	2022-05-31	2029-05-31	28,640	28,640	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2030-04-01	54,332	54,332	Direct
2031-04-01	82,066	82,066	Direct
2029-05-31	28,640	28,640	Direct

Footnotes

All sales were effected pursuant to a Rule 10b5-1 plan.
Represents weighted average sale price for this group of sales, which occurred on the same trading day. Multiple sales were executed, with sales prices ranging from $86.52 and $86.71 per share.
Option became exercisable in four equal annual installments, beginning on 4/1/2020.
Option became exercisable in four equal annual installments, commencing 4/1/2021.
Option becomes exercisable in four equal installments, commencing 4/1/2022.
Option becomes exercisable in three equal installments, commencing 5/31/2022.